The Swiss drugmaker Roche’s race to join the likes of Novo Nordisk and Eli Lilly in the booming obesity treatment market appears to be taking shape. Roche said its weight-loss drug delivered almost 19% weight loss in early trials. Swetha Ramachandran from Artemis gave her verdict on whether it can compete effectively in this space.
#News #obesitymedicine #treatment #Reuters #Newsfeed
Read the story here:
???? Subscribe: http://smarturl.it/reuterssubscribe
Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
#News #obesitymedicine #treatment #Reuters #Newsfeed
Read the story here:
???? Subscribe: http://smarturl.it/reuterssubscribe
Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
- Category
- World
- Tags
- reuters, news, world news today
Sign in or sign up to post comments.
Be the first to comment